Navigation Links
Statement from ASH President Armand Keating, M.D., on FDA action to alleviate drug shortages
Date:2/21/2012

(WASHINGTON, February 21, 2012) The American Society of Hematology (ASH) is encouraged by the steps FDA is taking to alleviate drug shortages that have significantly affected so many patients with hematologic malignancies under our members' care. The measures announced today are consistent with the Society's recommendations to FDA, Congress, and the Obama Administration to expand the agency's authority to prevent drug shortages by requiring manufacturers to provide early notification of impending shortages and importing drugs in critical supply.

While ASH applauds the specific actions announced today, we also realize that these measures represent only a portion of a solution to a much larger problem. In addition to these steps, additional measures - such as developing a national drug registry and providing economic incentives to manufacturers to produce a steady supply of generics - must be implemented to permanently prevent shortages. Until a complete solution is in place, treatment will be delayed and care will be rationed for critically ill patients. ASH will continue to support legislative, regulatory, and policy changes that will give FDA the ability to prevent and mitigate drug shortages before they progress to crisis status.


'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
202-552-4927
American Society of Hematology
Source:Eurekalert

Page: 1

Related medicine news :

1. American Society of Hematology statement on critical methotrexate drug shortage
2. ATS issues joint statement on key issues and recommendations for critical care research
3. ACR and SBI issue statement on British Medical Journal article on effect of mammography on breast cancer death rates
4. EMAS publishes position statement about the post-reproductive health of women
5. AMP releases statement on diagnostics in drug labels
6. Radiation risks to health: A joint statement from leading scientific experts
7. ATS issues joint statement on the treatment of idiopathic pulmonary fibrosis
8. ATS issues statement on the treatment of pulmonary fungal infections
9. IOF statement on new IOM dietary reference intakes for calcium and vitamin D
10. EMAS publishes position statements about the post-reproductive health of women
11. AAO-HNS releases consensus statement: diagnosis and management of nasal valve compromise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... FRANCISCO AND TEL AVIV (PRWEB) , ... June ... ... 3D-imaging sensor company whose technology makes it possible to see through objects, has ... challenging makers to create consumer apps with its fully programmable, Raspberry Pi-enabled 3D ...
(Date:6/28/2017)... ... June 28, 2017 , ... Drs. Steven Crandall, Karen ... treatment in Pittsburgh, PA, and Upper St. Clair, PA, without a referral. The doctors ... restoring the health of the temporomandibular joint and facial muscles that support it. ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... David B. Sosin, a founding ... Illinois, took over the post of 2nd Vice President for the Illinois State Bar ... installed as the ISBA’s 3rd Vice President in 2016 following a state-wide election and served ...
(Date:6/28/2017)... ... 2017 , ... Schneider Insurance and Financial, a Yellowstone County ... Montana, is announcing a focused charity effort to gather regional support for the ... Zoo Montana provide students with current knowledge on the characteristics and behaviors of ...
(Date:6/27/2017)... ... June 27, 2017 , ... Nearly ... to survey data released today by the American Society for Dermatologic Surgery ... indicates the percentage of consumers considering a cosmetic medical procedure has doubled since ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)...  NxStage Medical, Inc. (Nasdaq:  NXTM), a leading medical technology company ... demonstrating positive biochemical outcomes related to more frequent hemodialysis ... will be presented at the ERA-EDTA Congress being held ... . The research was conducted by ... Europe (KIHDNEy) Cohort team ...
(Date:5/30/2017)... 2017 DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... that it will be presenting at the 7th annual LD Micro ... Erez Raphael , CEO, of DarioHealth will be giving the presentation ... on June 6th & 7th, 2017 at the Luxe Sunset Bel ... micro-cap space. About LD Micro ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: